Literature DB >> 6154154

Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

R J Versteegen, S Oroszlan.   

Abstract

The effects of protein modification on the antigenic determinants of p30 and gp70 of type C retroviruses were investigated by using solid-phase competition radioimmunoassays. Proteins were modified by reduction with 2-mercaptoethanol and subsequent carboxymethylation of SH groups with iodoacetamide or by amidination of alpha and epsilon amino groups with methylacetimidate. The type-specific determinants of gp70 were found to be conformational in nature, as they were destroyed by these chemical modifications. Group- and interspecies-specific determinants of gp70 antigens, however, appear to be sequential and do not involve residues susceptible to these chemical reagents. Conformation-dependent type-specific determinants of p30 were affected only by methylacetimidate. Group- and interspecies-specific determinants of p30 are similar to those of gp70 in that they also appear to be sequential antigenic sites. Therefore, the broadly reactive group- and interspecies-specific determinants of gp70 and p30 can be followed into small peptides. Accordingly, a cyanogen bromide cleavage fragment derived from the carboxyl-terminal one-third of Rauscher leukemia virus p30 was found to carry group-specific determinants but no detectable interspecies-specific determinants. In contrast, a peptide obtained by limited trypsin cleavage of p30, which was derived from the NH(2)-terminal region of the protein, contained at least one of the interspecies determinants shared with feline leukemia virus p27.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154154      PMCID: PMC288632          DOI: 10.1128/JVI.33.3.983-992.1980

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum.

Authors:  G Hunsmann; V Moennig; W Schäfer
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen.

Authors:  M Strand; J T August
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

3.  Isolation of an immunogenic polypeptide after limited trypsin hydrolysis of murine leukemia virus group-specific antigen.

Authors:  J Davis; R V Gilden; S Oroszlan
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

4.  Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein.

Authors:  M Strand; J T August
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Enzymic and immunochemical properties of lysozyme. Evaluation of several amino group reversible blocking reagents.

Authors:  A F Habeeb; M Z Atassi
Journal:  Biochemistry       Date:  1970-12-08       Impact factor: 3.162

7.  Multiple species-specific and interspecific antigenic determinants of a mammalian type C RNA virus internal protein.

Authors:  J Davis; R V Gilden; S Oroszlan
Journal:  Immunochemistry       Date:  1975-01

8.  Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing.

Authors:  S Oroszlan; C L Fisher; T B Stanley; R V Gilden
Journal:  J Gen Virol       Date:  1970-07       Impact factor: 3.891

9.  Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.

Authors:  R A Steeves; M Strand; J T August
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

10.  Murine type-C virus group-specific antigens: interstrain immunochemical, biophysical, and amino acid sequence differences.

Authors:  S Oroszlan; M R Summers; C Foreman; R V Gilden
Journal:  J Virol       Date:  1974-12       Impact factor: 5.103

View more
  14 in total

1.  Suppression of UAA and UGA termination codons in mutant murine leukemia viruses.

Authors:  Y X Feng; J G Levin; D L Hatfield; T S Schaefer; R J Gorelick; A Rein
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

2.  Induction of endogenous xenotropic retrovirus expression by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.

Authors:  W A Suk; C W Long
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

3.  Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus.

Authors:  A Rein; M R McClure; N R Rice; R B Luftig; A M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication.

Authors:  G Natsoulis; P Seshaiah; M J Federspiel; A Rein; S H Hughes; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

5.  Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CNBr cleavage fragments.

Authors:  B Dietzschold; T J Wiktor; R Macfarlan; A Varrichio
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  Molecular properties of a gag- pol- env+ murine leukemia virus from cultured AKR lymphoma cells.

Authors:  A Rein; D R Lowy; B I Gerwin; S K Ruscetti; R H Bassin
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

7.  Biological, chemical, and immunological studies of Rauscher ecotropic and mink cell focus-forming viruses from JLS-V9 cells.

Authors:  A Schultz; A Rein; L Henderson; S Oroszlan
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

8.  Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein.

Authors:  A Rein; D E Ott; J Mirro; L O Arthur; W Rice; L E Henderson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.

Authors:  A Rein; D P Harvin; J Mirro; S M Ernst; R J Gorelick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.

Authors:  D Ott; A Rein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.